Cargando…

Avelumab/pembrolizumab: COVID-19 infection and recurrent infusion reactions: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546925/ http://dx.doi.org/10.1007/s40278-020-84296-9

Ejemplares similares

Antithrombotics/elasomeran/pembrolizumab: Infusion site reaction in the form of skin necrosis: case report
Publicado: (2022)

Pembrolizumab: COVID-19 infection: case report
Publicado: (2021)

Rapid Onset of Takotsubo Cardiomyopathy Induced by an Infusion Reaction to Pembrolizumab in a Patient with NSCLC
por: Okamatsu, Yuki, et al.
Publicado: (2020)

Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case report
por: Lehmann, M., et al.
Publicado: (2023)

Avelumab inducing hypothyroidism and hypoadrenalism: A case report and review of literature
por: Aziz, Kashif, et al.
Publicado: (2018)

Avelumab in metastatic collecting duct carcinoma of the kidney: a case report
por: Pyrgidis, Nikolaos, et al.
Publicado: (2023)

Carboplatin/pembrolizumab/pemetrexed: COVID-19 pneumonia: case report
Publicado: (2021)

Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report
por: Leão, Inês, et al.
Publicado: (2021)

A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer
por: Hayakawa, Nozomi, et al.
Publicado: (2022)

Antineoplastics: Lack of efficacy and infusion reaction: case report
Publicado: (2022)

A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab
por: Sh Ahmed, Omar, et al.
Publicado: (2022)

Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports
por: Thomsen, Kenneth, et al.
Publicado: (2018)

Pembrolizumab: Various toxicities: case report
Publicado: (2021)

Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by pembrolizumab: A case report
por: Yu, Xiao-He, et al.
Publicado: (2021)

Remdesivir: Infusion site reaction following extravasation of remdesivir: case report
Publicado: (2021)

Pembrolizumab: Interstitial bilateral pneumonitis: case report
Publicado: (2021)

Pembrolizumab: Secondary haemophagocytic lymphohistiocytosis: case report
Publicado: (2021)

Pembrolizumab: Guillain Barre Syndrome: case report
Publicado: (2021)

Pembrolizumab: Immune-mediated pancreatitis: case report
Publicado: (2022)

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2022)

Intravenous lidocaine infusion in a case of severe COVID-19 infection
por: Rylova, Anna, et al.
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech/pegfilgrastim/pembrolizumab: Large vessel vasculitis: case report
Publicado: (2022)

Rituximab: Hypogammaglobulinaemia and recurrent COVID-19 infection: case report
Publicado: (2022)

An Atypical Presentation of Lichen Planus-Like Reaction from Pembrolizumab
por: Lee, Matthew, et al.
Publicado: (2019)

Pembrolizumab: Pneumonitis, pulmonary cavitation and haemoptysis: case report
Publicado: (2020)

Axitinib/pembrolizumab: Tumour-lysis-syndrome: case report
Publicado: (2020)

Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report
por: Mahmood, Israa, et al.
Publicado: (2020)

Complete response to pembrolizumab in recurrent nested variant of urothelial carcinoma
por: Fukuta, Kyotaro, et al.
Publicado: (2021)

Pembrolizumab for Refractory Metastatic Myxofibrosarcoma: A Case Report
por: Song, Haa-Na, et al.
Publicado: (2018)

Pembrolizumab: Subacute cutaneous lupus erythematosus: case report
Publicado: (2021)

Pembrolizumab-induced toxic epidermal necrolysis: case report
por: Chow, Kar Ven Cavan, et al.
Publicado: (2022)

Pembrolizumab induced pericardial tamponade: A case report
por: Uczkowski, Dariusz, et al.
Publicado: (2023)

Late Reaction to Ustekinumab Infusion
por: Morais, Marina Resener, et al.
Publicado: (2013)

Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma
por: Tun Min, Sandy, et al.
Publicado: (2019)

Avelumab-Induced Scleroderma in a Patient with Metastatic Squamous Cell Carcinoma of the Lung
por: Dobrzynski, Jeffrey L., et al.
Publicado: (2022)

Case report: Postoperative abdominal recurrence of pulmonary pleomorphic carcinoma showed a dramatic response to S-1 after pembrolizumab
por: Kojima, Yuichi, et al.
Publicado: (2021)

25 Immune Complex Mediated Proliferative Glomerulonephritis Associated With Avelumab and COVID-19 Infection
Publicado: (2023)

Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report
por: Cardis, Michael A., et al.
Publicado: (2019)

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
por: Hunt, Jonathan T., et al.
Publicado: (2021)

Successful treatment of recurrent small cell carcinoma of urinary bladder with pembrolizumab
por: Hatayama, Tomoya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_00vs2ur4csidra0too58s80uim